In the BPC-157 vs TB-500 comparison, BPC-157 is characterised as a local, angiogenesis-focused peptide most studied in tendon, ligament and gut tissue, while TB-500 is described as a systemic, cell-migration peptide studied across cardiac, neural and multi-tissue models
PubMed laboratory research record [PMID: 6117529] PubMed record related to this compound for laboratory literature review
Commonly used for weight loss, energy, pernicious anemia, schilling test and overall health.
Because NAD is a critical cofactor for cellular energy production, DNA repair, and sirtuin activity, modulation of this pathway has attracted growing interest in metabolic disease and healthy aging research
Plenty of vendors charge more than $36 for just 5mg, half the peptide
Additionally, TB-500 demonstrates cardioprotective effects through preservation of cardiac muscle viability following ischemic injury and promotion of cardiac muscle regeneration